The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset

Our results suggest that mianserin, a clinically-available anti-depressant, may be effective to alleviate both PD psychosis and dyskinesia, but may hinder l-DOPA anti-parkinsonian action, which limits its potential clinical usefulness.